Avestar Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $357K | Buy |
5,167
+334
| +7% | +$23.1K | 0.02% | 321 |
|
|
2025
Q1 | $341K | Sell |
4,833
-2,219
| -31% | -$157K | 0.03% | 305 |
|
|
2024
Q4 | $607K | Sell |
7,052
-146
| -2% | -$12.6K | 0.05% | 224 |
|
|
2024
Q3 | $857K | Sell |
7,198
-389
| -5% | -$46.3K | 0.09% | 166 |
|
|
2024
Q2 | $1.08M | Buy |
7,587
+3,196
| +73% | +$456K | 0.11% | 123 |
|
|
2024
Q1 | $564K | Buy |
4,391
+3,866
| +736% | +$496K | 0.06% | 202 |
|
|
2023
Q4 | $54.3K | Buy |
+525
| New | +$54.3K | 0.01% | 353 |
|
|
2019
Q3 | – | Sell |
-798
| Closed | -$18K | – | 622 |
|
|
2019
Q2 | $18K | Hold |
798
| – | – | 0.01% | 406 |
|
|
2019
Q1 | $20K | Buy |
798
+50
| +7% | +$1.25K | 0.01% | 376 |
|
|
2018
Q4 | $15K | Buy |
748
+68
| +10% | +$1.36K | 0.01% | 377 |
|
|
2018
Q3 | $13K | Sell |
680
-252
| -27% | -$4.82K | 0.01% | 425 |
|
|
2018
Q2 | $18K | Sell |
932
-122
| -12% | -$2.36K | 0.01% | 378 |
|
|
2018
Q1 | $24K | Sell |
1,054
-266
| -20% | -$6.06K | 0.02% | 310 |
|
|
2017
Q4 | $33K | Buy |
+1,320
| New | +$33K | 0.02% | 291 |
|